Abstract

Aims Cardiac magnetic resonance perfusion imaging (CMRI) is a promising technique for non-invasive measurement of myocardial perfusion reserve. Fractional flow reserve (FFR) is an established invasive method for functional assessment of coronary artery disease (CAD). To prospectively assess the diagnostic value of CMRI for the detection of haemodynamically significant coronary lesions, compared with coronary angiography (CA) and FFR.

Methods and results Forty-three patients with suspected or known CAD underwent CA, CMRI, and FFR measurement. First pass magnetic resonance perfusion examination was performed during hyperaemia (140 µg/kg/min adenosine over 6 min) and at rest. One hundred and twenty-nine perfusion territories were assessed by semi-quantitative evaluation of signal intensity–time curves using the myocardial perfusion reserve index (MPRI) [upslopestress(corrected)/upsloperest(corrected)]. Perfusion territories were categorized as normal (coronary stenosis≤50%), intermediate (stenosis>50% and FFR>0.75), or severe (stenosis>50% and FFR≤0.75 or total occlusion). MPRI values (±SD) were significantly different between the three categories [normal, 2.2±0.5 vs. intermediate, 1.8±0.5 (P=0.005) and intermediate vs. severe, 1.2±0.3 (P<0.001)]. An MPRI cut-off value of 1.5 (derived from receiver operating characteristics analysis) distinguished haemodynamically relevant (severe) from non-relevant (normal and intermediate) stenoses with a sensitivity of 88% (CI 74–100%) and a specificity of 90% (CI 84–96%).

Conclusion In contrast to earlier studies that compared CMRI with morphological examination (CA) alone, the present study compared CMRI with CA plus a standard invasive functional assessment (FFR) and demonstrated that CMRI is able to distinguish haemodynamically relevant from non-relevant coronary lesions with a high sensitivity and specificity and may therefore contribute to clinical decision-making.

Introduction

Despite recent advances in non-invasive imaging techniques, coronary angiography (CA) remains the standard method for morphological assessment of coronary artery disesase (CAD). Patient prognosis, however, is more closely related to the functional significance of the disease.1–3 For example, patients with no evidence of myocardial ischaemia have low cardiac event rates, despite demonstrating coronary artery lesions of intermediate severity.4–6 To assess the functional severity of coronary stenoses, measurement of the pressure-derived fractional flow reserve (FFR) has become a well-established invasive standard of reference.4,7 FFR represents the ratio of maximal coronary blood flow in the presence of a stenosis to the maximum achievable blood flow if all epicardial obstructions were absent.8 Measurement of FFR has the disadvantage of being invasive and associated with radiation exposure. Conversely, cardiac magnetic resonance perfusion imaging (CMRI) offers the possibility to assess myocardial blood flow non-invasively and without radiation exposure, recording the myocardial signal intensity over time characteristics of the first pass of a T1-shortening contrast agent.9–13 CMRI has been extensively validated in animals and healthy volunteers;10,11,14 also CMRI has shown promising results when compared with CA or positron emission tomography (PET).15,16 Ishida et al.17 found that in 104 patients without myocardial infarction, stress enhancement as measured by dynamic MR imaging correlates more closely with quantitative CA results than does stress enhancement as measured by SPECT. The aim of this study was to estimate the sensitivity and specificity of CMRI and to determine the optimal cut-off for the detection of haemodynamically relevant coronary lesions, using the combination of CA and FFR as the reference standard.

Methods

Patients

Of 79 patients, referred for diagnostic CA for clinically suspected CAD or progression of existing CAD, 50 patients met the inclusion criteria and were willing to participate. Exclusion criteria included contraindications to CMRI, intolerance to the used pharmacological agents, or refusal to participate as well as the presence of acute coronary syndromes within the preceding 30 days. Of these 50 patients, seven had to be excluded due to technical reasons (MRI, n=4; FFR measurement, n=2) or claustrophobia (n=1). The remaining 43 patients were included in the data analysis. Demographic and clinical characteristics were recorded [hypertension (≥140/≥90 mmHg), diabetes (non-insulin-dependent or insulin-dependent), angina class, family history of CAD]. All patients underwent CMRI and CA within 4 weeks. FFR measurement was performed if angiography indicated a coronary stenosis of >50–99% (100% stenosis does not allow a pressure wire to be passed). The study protocol was approved by the local Ethics Committee and written informed consent was obtained.

Coronary angiography

All patients underwent CA by the femoral approach. At least two orthogonal views were obtained with the projection showing the most severe narrowing used for quantitative coronary measurements (Philips DCI, Eindhoven, The Netherlands). An intracoronary bolus of 0.25 mg nitroglycerine was administered for maximum dilatation of the epicardial vessels. Using the guiding catheter as a scaling device, lesion length, minimal lumen diameter, and proximal and distal reference diameter were calculated (CAAS II, Pie Medical, Maastricht, The Netherlands). If more than one coronary artery stenosis was present within the same perfusion territory, the most severe stenosis was used. For subsequent analysis, the coronary tree was divided into 15 segments18 [right coronary artery (RCA) 1–4, LM and left anterior descending artery (LAD) 5–10, and left circumflex artery (LCx) 11–15]. The segments 1, 2, 5, 6 and 11 were defined as proximal and the remaining segments as distal segments.

FFR measurement

FFR was measured with a sensor-tipped 0.014 in. angioplasty guidewire (PressureWire™, Radi Medical Systems, Uppsala, Sweden). After crossing the target lesion with the wire, hyperaemia was induced by an infusion of 140 µg/kg/min adenosine (Adrekar™, Sanofi, Munich, Germany). The maximum pressure gradient was used to calculate FFR, defined as the ratio of mean post-stenotic pressure vs. mean aortic pressure (measured via the guiding catheter) during maximum hyperaemia.

Cardiac magnetic resonance perfusion imaging

Patients were examined in the supine position with a 1.5 T whole body MR-tomograph (Sonata, Siemens Medical Solutions, Erlangen, Germany) equipped with eight independent receiver channels using a 12-element body-phased array cardiac surface coil. During the examination, blood pressure and ECG were continuously recorded. After two rapid surveys to determine the exact position of the heart, three parallel short-axis views (basal, mid-papillary, and apical) were chosen for perfusion imaging. We used a T1-weighted saturation recovery turbo flash sequence (flip angle 12°, TE 1.0 ms, acquisition window 192 ms, inversion time 100 ms, 128 phase-encoding lines) with prospective ECG triggering. Slice thickness was 10 mm. With a typical field-of-view of 340×265 mm2, the in-plane spatial resolution was 2.7×2.1 mm. Hyperaemia was induced with a continuous (6 min) intravenous injection of 140 µg/kg/min adenosine (Adrekar) via a venous line. A bolus of gadodiamide (Omniscan, GE Healthcare, Buckinghamshire, UK) 0.05 mmol/kg body weight with a flow rate of 5 mL/s followed by 20 mL saline solution using an MR-compatible automatic injector (Spectris, Medrad, Indianola, PA, USA) was administered via a separate cannula in the opposite arm while the adenosine injection was continued. To minimize breathing artefacts, care was taken to achieve breath-holding during the first pass of the contrast agent through the myocardium. The resting perfusion examination was performed 10 min after the stress examination and discontinuation of the adenosine infusion, using a second bolus of contrast agent. Flow rates, dosage, slice position, and pulse sequence parameters were identical to those used for the stress examination.

Image analysis

Data was analysed off-line by means of a commercially available dedicated software tool (Dynamic Signal Analysis, Argus, Siemens Medical Solutions). Subendocardial and subepicardial borders were positioned on each slice on a frame with high contrast between left ventricular (LV) cavity and myocardium. The borders were propagated by the software on all frames with a semi-automated contour correction. An interactive correction was done if necessary. The LV myocardium was divided into six equiangular segments per slice, according to the modified standardized nomenclature for tomographic imaging of the heart,19 resulting in a total number of 36 segments per patient (18 for the stress examination and 18 for the resting examination).

Mean signal intensity for each myocardial segment was registered over time and signal intensity–time curves were obtained. Signal intensity in different myocardial segments may be somewhat variable-dependent on the coil sensitivity profile. In order to eliminate signal inhomogeneities caused by the location of the segment and the surface coil, a baseline and coil normalization was performed using the following equation:  

$$\hbox{Signal}_{\rm corrected} = {\hbox{Mean}_{\rm Baseline/Segment} \over \hbox{Mean}_{\rm Baseline/All segments}} {}* \hbox{Signal}_{\rm Source data} - \hbox{Mean}_{\rm Baseline/Segment}$$
MeanBaseline/Segment is the mean value of the consecutive signal values of the baseline in the individual segment. MeanBaseline/All segments is the mean value of the consecutive signal values of the baselines of all segments in three slices. SignalSource data is the signal intensity value at one time point of the signal intensity curve within one segment without any correction. Signalcorrected is the resulting value of signal intensity at one time point of the signal intensity curve within one segment with completed correction. Using this equation, a normalization of the curves and a subtraction of the baseline was performed. For each signal intensity–time curve, the foot point and the point of signal maximum were determined by the software. A straight-line model was used for a linear fit of the data. The linear fit was based on the least-squares regression line, the most commonly used method. Signal maximum was defined as the data point with the highest value of signal intensity. Both data points (foot point, signal maximum) were corrected interactively if necessary. The downslope data points were excluded from the evaluation to avoid the effect of contrast material diffusion into the interstitial space.

The upslope values of the line were used for further calculations. The upslope values of all segments (USsegment) were divided by the upslope value of the signal intensity–time curve in the LV cavity (USLV cavity) obtained from the same slice as the myocardial segment's curve was. The signal intensity–time curve of the LV cavity served as input function.15 After normalization by the USLV cavity (UScorrected=USsegment/USLV cavity),15,20 the myocardial perfusion reserve index (MPRI) was calculated by division of the corrected upslope of the stress examination by the corresponding segment's corrected upslope value of the rest examination [MPRI: upslopestress (corrected)/upsloperest (corrected)]. The MPRI served as a semi-quantitative estimation of the perfusion reserve. According to the coronary dominance, the segments were assigned to the respective perfusion territory19 and the mean value of the two lowest scoring segments for each perfusion territory was used for further analysis.

Statistical analysis

All perfusion territories were classified as normal, intermediate, or severe, according to the coronary angiogram and FFR measurements. A perfusion territory was classified as normal if CA showed no significant stenosis (≤50%). A perfusion territory was classified as intermediate if it encompassed a lesion with a stenosis of >50% and an FFR>0.75. A territory was classified as severe if there were lesions of >50% and an FFR≤0.75 or a total occlusion. A dichotomous classification was also defined to allow for analysis of sensitivity and specificity: normal and intermediate results were considered negative and severe results as positive.

Descriptive analysis for categorical and continuous parameters was performed using the software package SPSS version 13.0 (SPSS, Chicago, IL, USA) and SAS version 9.1 (SAS Institute Inc., Cary, NC, USA). All data are presented as mean±standard deviation for continuous data and as proportions for binary data.

As three territories have been measured in each patient, data on the territory level may not be independent. We accounted for this fact by using generalized estimation equations (GEEs) methods for statistical tests. All statistical tests were two-sided. We used an alpha level of 0.05 and adjusted for pairwise comparisons using the Bonferroni method.

We estimated the area under the receiver operating characteristics (ROC) curve using the approach by Liu and Wu21 For exploratory purposes, the optimal cut-off for MPRI value was defined as the value that maximized the sum of sensitivity and specificity. Confidence intervals for sensitivity and specificity were calculated according to the approach of Zhou et al.22

Results

A total of 129 perfusion territories were analysed: three territories in each of the 43 consecutive patients. The patients were 88% male, average age of 65.5±8 years (Table 1). Twenty-three patients (53%) experienced stable angina and the remaining 20 patients (47%) had no typical angina but had inconclusive stress tests or were scheduled for control angiography for clinical reasons. Characteristics of the perfusion territories are given in Table 2. Seventy-six (59%) territories were normal, 29 (22%) were intermediate, and 24 (19%) were severe according to the previously defined criteria. No significant differences were noted regarding the clinical characteristics (sex, hypertension, diabetes, familial history, angina class).

Table 1

Patient clinical characteristics

Clinical characteristics  
 Male 38 (88) 
 Smoking 15 (35) 
 Hypertension 37 (86) 
 Diabetes 10 (23) 
 Familial history 7 (16) 
 Angina present 23 (53) 
 Prior MI 8 (19) 
 Prior coronary intervention 12 (28) 
 Mean age (years) 65.5±8.1 
 LVEF (%) 58±9 
Angiographic characteristics  
 No relevant CAD 14 (33) 
 Single-vessel disease 12 (28) 
 Multi-vessel disease 17 (39) 
 At least one stenosis >30% in any coronary artery 43 (100) 
Clinical characteristics  
 Male 38 (88) 
 Smoking 15 (35) 
 Hypertension 37 (86) 
 Diabetes 10 (23) 
 Familial history 7 (16) 
 Angina present 23 (53) 
 Prior MI 8 (19) 
 Prior coronary intervention 12 (28) 
 Mean age (years) 65.5±8.1 
 LVEF (%) 58±9 
Angiographic characteristics  
 No relevant CAD 14 (33) 
 Single-vessel disease 12 (28) 
 Multi-vessel disease 17 (39) 
 At least one stenosis >30% in any coronary artery 43 (100) 

Values are numbers of patients or mean±SD (per cent of all 43 patients). Coronary single-vessel disease was defined as the presence of one vessel with a diameter stenosis>50%. Multi-vessel disease was defined as the presence of diameter stenosis of >50% in at least two vessels.

Table 2

Clinical and procedural characteristics of perfusion territories

 Normal territories (n=76) Intermediate territories (n=29) Severe territories (n=24) P-value 

 
Clinical characteristics     
 Male 67 (88) 25 (86) 22 (92) 0.91 
 Smoking 26 (34) 8 (28) 11 (46) 0.44 
 Hypertension 66 (87) 26 (90) 19 (79) 0.80 
 Diabetes 12 (16) 12 (41) 6 (25) 0.12 
 Familial history 11 (15) 5 (17) 5 (21) 0.78 
 Angina class 1.82±0.9 1.72±0.8 1.92±1.0 0.79 
Angiographic characteristics     
 Single-vessel disease 24 (32) 8 (28) 4 (17) 0.024 
 Multi-vessel disease 10 (13) 21 (72) 20 (83) 0.024 
 RCA 26 (34) 9 (31) 8 (33) 0.94 
 LAD 22 (29) 11 (38) 10 (42) 0.55 
 Left CX 28 (37) 9 (31) 6 (25) 0.60 
 Proximal segment 25 (54a17 (59) 15 (63) 0.74 
 Distal segment 21 (46a12 (41) 9 (38) 0.74 
 Diameter stenosis (%) 24±21 59±6 84±17 <0.001 
Functional characteristics     
 FFR n.a. 0.87±0.07 0.61±0.1  
 MPRI 2.2±0.5 1.8±0.5 1.2±0.3 <0.001 
 Normal territories (n=76) Intermediate territories (n=29) Severe territories (n=24) P-value 

 
Clinical characteristics     
 Male 67 (88) 25 (86) 22 (92) 0.91 
 Smoking 26 (34) 8 (28) 11 (46) 0.44 
 Hypertension 66 (87) 26 (90) 19 (79) 0.80 
 Diabetes 12 (16) 12 (41) 6 (25) 0.12 
 Familial history 11 (15) 5 (17) 5 (21) 0.78 
 Angina class 1.82±0.9 1.72±0.8 1.92±1.0 0.79 
Angiographic characteristics     
 Single-vessel disease 24 (32) 8 (28) 4 (17) 0.024 
 Multi-vessel disease 10 (13) 21 (72) 20 (83) 0.024 
 RCA 26 (34) 9 (31) 8 (33) 0.94 
 LAD 22 (29) 11 (38) 10 (42) 0.55 
 Left CX 28 (37) 9 (31) 6 (25) 0.60 
 Proximal segment 25 (54a17 (59) 15 (63) 0.74 
 Distal segment 21 (46a12 (41) 9 (38) 0.74 
 Diameter stenosis (%) 24±21 59±6 84±17 <0.001 
Functional characteristics     
 FFR n.a. 0.87±0.07 0.61±0.1  
 MPRI 2.2±0.5 1.8±0.5 1.2±0.3 <0.001 

Values are numbers of territories or mean±SD (per cent of the respective number of territories). P-values are those between different categories by GEEs.

aPer cent of territories with visible stenoses.

Coronary angiography

CA was carried out in all 43 patients. An overview of all angiographic characteristics is provided in Table 2. A normal angiography was noted in 30 (23%) perfusion territories. Angiographic stenosis of ≤50% was present in 46 (36%) cases. Fifty-three (41%) perfusion territories revealed an angiographic stenosis >50%. Stenoses were located: LAD=38 (38%), LCx=32 (32%), and RCA=29 (29%). Fifty-seven (58%) lesions were proximal and 42 (42%) distal. The overall mean diameter stenosis was 43±30% and was significantly different between the three categories (P<0.001). Eleven coronary arteries were totally occluded, six proximal and five distal. However, at least partial collateral filling (≥Rentrop grade 2)23 was present in seven (64%) of the occluded arteries (Table 3).

Table 3

Collateralization of occluded vessels

Sample Vessel Location MPRI Rentrop grade 

 
0603 RCA Prox 0.83 
1501 LAD Dist 0.93 
1602 LCx Dist 1.06 
5101 LAD Prox 1.28 
0103 RCA Prox 1.48 
0302 LAD Dist 1.29 
1303 RCA Prox 1.32 
1403 RCA Prox 1.48 
2501 LAD Dist 1.35 
2801 LAD Dist 1.14 
3202 LCx Prox 1.75 
Sample Vessel Location MPRI Rentrop grade 

 
0603 RCA Prox 0.83 
1501 LAD Dist 0.93 
1602 LCx Dist 1.06 
5101 LAD Prox 1.28 
0103 RCA Prox 1.48 
0302 LAD Dist 1.29 
1303 RCA Prox 1.32 
1403 RCA Prox 1.48 
2501 LAD Dist 1.35 
2801 LAD Dist 1.14 
3202 LCx Prox 1.75 

Prox, proximal location; Dist, distal location; Rentrop grades, collateral filling grades: 0, none; 1, filling of branches of the artery to be dilated via collateral channels without visualization of the epicardial segment; 2, partial filling of the epicardial segments via collateral channels; 3, complete filling of the epicardial segment of the artery being dilated via collateral channels.

FFR measurement

FFR measurement was performed in 42/129 territories. FFR values ranged from 0.38 to 1.0 with a mean FFR of 0.79±0.1. In 11 territories, an FFR measurement could not be performed due to a complete occlusion of the coronary vessel. In 13/42 (31%) territories, the FFR was significantly reduced (FFR≤0.75), whereas 29 (69%) territories revealed an FFR above 0.75.

The degree of angiographic stenosis correlated only moderately with the FFR (r=0.64, P<0.001).

Cardiac magnetic resonance perfusion imaging

CMRI was successfully performed in all 43 patients giving 129 perfusion territories. The mean MPRI was 1.9±0.6 (range: 0.6–4.4). The MPRI was highest in the normal category and significantly different between the remaining categories [normal, 2.2±0.5 vs. intermediate, 1.8±0.5 (P=0.005) and intermediate vs. severe, 1.2±0.3 (P<0.001)] (Figure 1). A moderate inverse correlation was observed between diameter stenosis and MPRI (r=−0.53; P<0.001) (Figure 2). Correlation between FFR and MPRI was higher (r=0.77, P<0.001). The MPRI values of perfusion segments in patients with diabetes but without a critically reduced FFR were significantly lower than perfusion segments in patients without diabetes (1.67±0.48 vs. 1.97±0.44, P=0.02). There was also a trend observed towards lower MPRI values in patients with hypertension and without critically reduced FFR (1.78±0.46 vs. 1.97±0.79, P=0.65).

Figure 1

Comparison of MPRI by category. Boxplots showing the median, quartiles, extreme values, and values out of range for each category.

Figure 1

Comparison of MPRI by category. Boxplots showing the median, quartiles, extreme values, and values out of range for each category.

Figure 2

Correlation of MPRI and diameter stenosis. This chart shows a moderate inverse correlation of the MPRI and the diameter stenosis by angiography. The filled markers indicate the perfusion territories where FFR measurement was performed.

Figure 2

Correlation of MPRI and diameter stenosis. This chart shows a moderate inverse correlation of the MPRI and the diameter stenosis by angiography. The filled markers indicate the perfusion territories where FFR measurement was performed.

ROC analysis for distinguishing the ‘severe’ category from the ‘normal’ and ‘intermediate’ category revealed an AUC derived from the ROC curves of 0.93. The sum of sensitivity (88%, CI 74–100%) and specificity (90%, CI 84–96%) was maximized (Figures 3 and 4) using an MPRI cut-off value of 1.5 (Figure 5).

Figure 3

Comparison of sensitivity and specificity for MPRI. This ROC curve provide the sensitivity and specificity of the MPRI to distinguish perfusion territories with a haemodynamically significant coronary stenosis.

Figure 3

Comparison of sensitivity and specificity for MPRI. This ROC curve provide the sensitivity and specificity of the MPRI to distinguish perfusion territories with a haemodynamically significant coronary stenosis.

Figure 4

Individual values of MPRI by category. This chart shows the individual MPRI values for the perfusion territories with normal, intermediate, and severe coronary stenosis. The optimal cut-off value for MPRI (1.5) is indicated.

Figure 4

Individual values of MPRI by category. This chart shows the individual MPRI values for the perfusion territories with normal, intermediate, and severe coronary stenosis. The optimal cut-off value for MPRI (1.5) is indicated.

Figure 5

Example of a CMRI study. This figure shows a CMRI study at stress (top row: Ia–c) and at rest (second row: IIa–c). The images represent a basal (a), mid-papillary (b), and apical (c) short-axis view. A stress-induced hypoperfusion was found in the antero-lateral wall (segments 7 and 12; indicated by arrows) with complete replenishment at rest. Exemplary, the corresponding time–intensitiy curves (IV) of segments 7 and 9 (III) at stress are provided.

Figure 5

Example of a CMRI study. This figure shows a CMRI study at stress (top row: Ia–c) and at rest (second row: IIa–c). The images represent a basal (a), mid-papillary (b), and apical (c) short-axis view. A stress-induced hypoperfusion was found in the antero-lateral wall (segments 7 and 12; indicated by arrows) with complete replenishment at rest. Exemplary, the corresponding time–intensitiy curves (IV) of segments 7 and 9 (III) at stress are provided.

Discussion

The primary objectives of this study were to prospectively assess the diagnostic value of CMRI (compared with the invasive reference standard FFR) and to determine the optimal cut-off value for distinguishing haemodynamically relevant from non-relevant coronary stenoses. For the measurement of absolute blood flow, PET remains the method of choice.24 However, PET is expensive and, due to the short half-lives of the typical tracers, limited to few specialized centres.25 In the presence of epicardial coronary artery stenoses, the coronary blood flow under stress is closely correlated to the FFR.26,27 In addition, FFR has been shown to predict outcomes in patients with CAD,6,7,28,29 but FFR measurement is invasive, limited to coronary catheterization procedures, and therefore associated with radiation exposure. In contrast, CMRI offers the potential to accurately measure the myocardial blood flow non-invasively and without radiation exposure.14 Contrast agent is administered in a bolus technique increasing the signal intensity of the perfused myocardium during the first pass. The MPRI values observed in the present study showed a very broad range but did not achieve values typically reported for the myocardial perfusion reserve in healthy subjects20 even in patients without evidence of epicardial stenoses. Also the high prevalences of diabetes and hypertension (seen even in the patients without relevant epicardial coronary stenoses) might contribute to this. Diabetes and hypertension often result in an endothelial microvascular dysfunction not detectable by FFR30 but potentially reducing MPRI.31 Mean MPRI was found to be significantly different between the three study categories: none, intermediate, and severe. ROC analysis gave a cut-off value of 1.5 for optimal discrimination between haemodynamically significant and non-significant lesions. Similar cut-off values have been reported in other myocardial perfusion imaging studies.15,32,33 These studies, however, used only CA as a reference examination; CA is a morphological method that seems inappropriate to evaluate a functional method like CMRI. Only a moderate correlation was observed between CMRI and diameter stenosis. FFR was also only moderately correlated to diameter stenosis, consistent with the published literature.34 FFR and MPRI, both functional methods, tend to show a higher correlation. Using the MPRI cut-off value of 1.5, we estimated CMRI test characteristics (sensitivity of 88% and specificity of 90%), comparable to earlier studies of Al-Saadi et al.15,20 that used only a single-slice technique and dipyridamole for pharmacological stress. Sensitivity of CMRI for the detection of ischaemic CAD was, in this limited number of patients, at least equal to the reported sensitivities of commonly used imaging techniques like dobutamine stress echocardiography (DSE) or SPECT (reported sensitivities between 67 and 82%).35,36 When sensitivity and specificity were determined for separate perfusion areas, CMRI remained at least equal to SPECT and DSE (sensitivity decreased markedly to levels of 44%35).

Mean MPRI was also significantly different between stenoses <50% and stenosis above 50% diameter, whereas FFR was not significantly changed. However, FFR values exhibited such a large overlap that no clear discrimination between groups was possible. One possible explanation for this is the differential effects of microvascular disease on MPRI vs. FFR: patients with perfusion areas with stenoses above 50% diameter tended to have a higher prevalence of microvascular dysfuncion than patients with no epicardial narrowing.37–39 In fact, perfusion segments in patients with diabetes and not critically reduced FFR revealed significantly lower MPRI values than in patients without.

Limitations

Our study has several limitations. First, FFR measurement was not performed in all coronary arteries; therefore, the reference standard is a combination of angiographic diameter stenosis measurements with and without corresponding FFR values. Coronary arteries with a diameter stenosis <50% were not assessed for cost reasons and to avoid potential iatrogenic complications. It is generally believed that lesions below 50% diameter stenosis are unlikely to cause ischaemia.40 Although care was taken to assess the coronary artery by several orthogonal projections, flow-limiting stenoses with a diameter reduction of <50% by CA cannot be fully ruled out. Coronary arteries with a total occlusion were not evaluated as the pressure wire is not designed to cross total occlusions. These lesions were all defined as functionally severe. Nevertheless, MPRI was only mildly decreased in some of such patients due to good collateralization (Rentrop grades 2 and 3).

A second limitation was the potential for case mix and spectrum biases. Our study population had high prevalence of CAD relative to the general population, so our reported values of sensitivity and specificity of CMRI have to be interpreted within this context. Thirdly, the assessment of the optimal cut-point was based on the criterion of maximizing the sum of sensitivity and specificity. However, the optimal cut-off depends on the tradeoff of the consequences (both clinical and economic) vs. a false-negative and a false-positive test result.41,42 Therefore, after validation of this cut-off value using an independent patient population, one of the next research tasks should be a full clinical and economic decision analysis evaluating different cut-off values.

Conclusion

On the basis of the results of this study, CMRI demonstrates good correlation with the invasive reference standard FFR in the functional assessment of coronary stenosis. An MPRI cut-off value of 1.5 distinguished haemodynamically significant from non-significant coronary lesions with a sensitivity of 88% (CI 74–100%) and a specificity of 90% (CI 84–96%), using conventional CA and FFR measurement as a reference examination. Because of this high sensitivity and specificity as well as the absence of ionizing radiation, CMRI may have the potential to contribute to non-invasive assessment of the haemodynamic relevance of coronary artery lesions.

Acknowledgements

A substantial part of this work originated from the doctoral theses of cand. med. Silvia Müller and cand. med. Michael Schweyer. The authors would like to express their gratitude to Vera Zietemann, Raffaella M. Gothe, and Elk Halpern for assistance in data analysis and to Pamela McMahon and Simon Thackray for assistance in preparation of the manuscript.

Conflict of interest: all contributing authors have nothing to disclose.

References

1
Beller
GA
Zaret
BL
Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease
Circulation
 , 
2000
, vol. 
101
 (pg. 
1465
-
1478
)
2
Gibbons
RS
American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines
J Nucl Cardiol
 , 
1996
, vol. 
3
 (pg. 
436
-
442
)
3
Shaw
LJ
Hachamovitch
R
Heller
GV
Marwick
TH
Travin
MI
Iskandrian
AE
Kesler
K
Lauer
MS
Hendel
R
Borges-Neto
S
Lewin
HC
Berman
DS
Miller
D
Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group
Am J Cardiol
 , 
2000
, vol. 
86
 (pg. 
1
-
7
)
4
Bech
GJ
De Bruyne
B
Bonnier
HJ
Bartunek
J
Wijns
W
Peels
K
Heyndrickx
GR
Koolen
JJ
Pijls
NH
Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement
J Am Coll Cardiol
 , 
1998
, vol. 
31
 (pg. 
841
-
847
)
5
Rieber
J
Jung
P
Schiele
TM
Koenig
A
Erhard
I
Segmiller
T
Ebel
S
Theisen
K
Siebert
U
Klauss
V
Safety of FFR-based treatment strategies: the Munich experience
Z Kardiol
 , 
2002
, vol. 
91
 
Suppl. 3
(pg. 
115
-
119
)
6
Rieber
J
Schiele
TM
Koenig
A
Erhard
I
Segmiller
T
Stempfle
HU
Theisen
K
Jung
P
Siebert
U
Klauss
V
Long-term safety of therapy stratification in patients with intermediate coronary lesions based on intracoronary pressure measurements
Am J Cardiol
 , 
2002
, vol. 
90
 (pg. 
1160
-
1164
)
7
Pijls
NH
Klauss
V
Siebert
U
Powers
E
Takazawa
K
Fearon
WF
Escaned
J
Tsurumi
Y
Akasaka
T
Samady
H
De Bruyne
B
Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry
Circulation
 , 
2002
, vol. 
105
 (pg. 
2950
-
2954
)
8
Pijls
NH
Van Gelder
B
Van der Voort
P
Peels
K
Bracke
FA
Bonnier
HJ
El Gamal
MI
Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow
Circulation
 , 
1995
, vol. 
92
 (pg. 
3183
-
3193
)
9
Manning
WJ
Atkinson
DJ
Grossman
W
Paulin
S
Edelman
RR
First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease
J Am Coll Cardiol
 , 
1991
, vol. 
18
 (pg. 
959
-
965
)
10
Keijer
JT
van Rossum
AC
van Eenige
MJ
Karreman
AJ
Hofman
MB
Valk
J
Visser
CA
Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging
Am Heart J
 , 
1995
, vol. 
130
 (pg. 
893
-
901
)
11
Wilke
N
Jerosch-Herold
M
Wang
Y
Huang
Y
Christensen
BV
Stillman
AE
Ugurbil
K
McDonald
K
Wilson
RF
Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging
Radiology
 , 
1997
, vol. 
204
 (pg. 
373
-
384
)
12
Stillman
AE
Wilke
N
Jerosch-Herold
M
Use of an intravascular T1 contrast agent to improve MR cine myocardial-blood pool definition in man
J Magn Reson Imaging
 , 
1997
, vol. 
7
 (pg. 
765
-
767
)
13
Jerosch-Herold
M
Wilke
N
MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow
Int J Card Imaging
 , 
1997
, vol. 
13
 (pg. 
205
-
218
)
14
Atkinson
DJ
Burstein
D
Edelman
RR
First-pass cardiac perfusion: evaluation with ultrafast MR imaging
Radiology
 , 
1990
, vol. 
174
 (pg. 
757
-
762
)
15
Al Saadi
N
Nagel
E
Gross
M
Bornstedt
A
Schnackenburg
B
Klein
C
Klimek
W
Oswald
H
Fleck
E
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance
Circulation
 , 
2000
, vol. 
101
 (pg. 
1379
-
1383
)
16
Schwitter
J
Nanz
D
Kneifel
S
Bertschinger
K
Buchi
M
Knusel
PR
Marincek
B
Luscher
TF
Von Schulthess
GK
Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography
Circulation
 , 
2001
, vol. 
103
 (pg. 
2230
-
2235
)
17
Ishida
N
Sakuma
H
Motoyasu
M
Okinaka
T
Isaka
N
Nakano
T
Takeda
K
Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography
Radiology
 , 
2003
, vol. 
229
 (pg. 
209
-
216
)
18
Galbraith
JE
Murphy
ML
de Soyza
N
Coronary angiogram interpretation. Interobserver variability
JAMA
 , 
1978
, vol. 
240
 (pg. 
2053
-
2056
)
19
Cerqueira
MD
Weissman
NJ
Dilsizian
V
Jacobs
AK
Kaul
S
Laskey
WK
Pennell
DJ
Rumberger
JA
Ryan
T
Verani
MS
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association
Circulation
 , 
2002
, vol. 
105
 (pg. 
539
-
542
)
20
Al Saadi
N
Gross
M
Bornstedt
A
Schnackenburg
B
Klein
C
Fleck
E
Nagel
E
Comparison of various parameters for determining an index of myocardial perfusion reserve in detecting coronary stenosis with cardiovascular magnetic resonance tomography
Z Kardiol
 , 
2001
, vol. 
90
 (pg. 
824
-
834
)
21
Liu
H
Wu
T
Estimating the Area under a Receiver Operating Characteristic Curve For Repeated Measures Design
Journal of Statistical Software
 , 
2003
, vol. 
8
 (pg. 
1
-
18
)
22
Zhou
XH
Obuchowski
A
McFadden
EP
Statistical Methods in Diagnostic Medicine
 , 
2002
Hoboken, NJ, USA
Wiley
pg. 
p105
 
23
Rentrop
KP
Cohen
M
Blanke
H
Phillips
RA
Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
J Am Coll Cardiol
 , 
1985
, vol. 
5
 (pg. 
587
-
592
)
24
Gibbons
R
Araoz
A
The year in cardiac imaging
J Am Coll Cardiol
 , 
2004
, vol. 
44
 (pg. 
1937
-
1944
)
25
Bol
A
Melin
JA
Vanoverschelde
JL
Baudhuin
T
Vogelaers
D
De Pauw
M
Michel
C
Luxen
A
Labar
D
Cogneau
M
Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres
Circulation
 , 
1993
, vol. 
87
 (pg. 
512
-
525
)
26
Pijls
NH
van Son
JA
Kirkeeide
RL
De Bruyne
B
Gould
KL
Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty
Circulation
 , 
1993
, vol. 
87
 (pg. 
1354
-
1367
)
27
De Bruyne
B
Baudhuin
T
Melin
JA
Pijls
NH
Sys
SU
Bol
A
Paulus
WJ
Heyndrickx
GR
Wijns
W
Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography
Circulation
 , 
1994
, vol. 
89
 (pg. 
1013
-
1022
)
28
Bech
GJ
Pijls
NH
De Bruyne
B
Peels
KH
Michels
HR
Bonnier
HJ
Koolen
JJ
Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty
Circulation
 , 
1999
, vol. 
99
 (pg. 
883
-
888
)
29
Rieber
J
Schiele
TM
Erdin
P
Stempfle
HU
Konig
A
Erhard
I
Segmiller
T
Baylacher
M
Theisen
K
Haufe
MC
Siebert
U
Klauss
V
Fractional flow reserve predicts major adverse cardiac events after coronary stent implantation
Z Kardiol
 , 
2002
, vol. 
91
 
Suppl. 3
(pg. 
132
-
136
)
30
Pijls-Nico
HJ
Kern
MJ
Yock
PG
De Bruyne
B
Practice and potential pitfalls of coronary pressure measurement
Catheter Cardiovasc Interv
 , 
2000
, vol. 
49
 (pg. 
1
-
16
)
31
McDonagh
PF
Hokama
JY
Microvascular perfusion and transport in the diabetic heart
Microcirculation
 , 
2000
, vol. 
7
 (pg. 
163
-
181
)
32
al Saadi
N
Gross
M
Paetsch
I
Schnackenburg
B
Bornstedt
A
Fleck
E
Nagel
E
Dobutamine induced myocardial perfusion reserve index with cardiovascular MR in patients with coronary artery disease
J Cardiovasc Magn Reson
 , 
2002
, vol. 
4
 (pg. 
471
-
480
)
33
al Saadi
N
Nagel
E
Gross
M
Schnackenburg
B
Paetsch
I
Klein
C
Fleck
E
Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging
J Am Coll Cardiol
 , 
2000
, vol. 
36
 (pg. 
1557
-
1564
)
34
McClish
JC
Ragosta
M
Powers
ER
Barringhaus
KG
Gimple
LW
Fischer
J
Garnett
J
Siadaty
M
Sarembock
IJ
Samady
H
Effect of acute myocardial infarction on the utility of fractional flow reserve for the physiologic assessment of the severity of coronary artery narrowing
Am J Cardiol
 , 
2004
, vol. 
93
 (pg. 
1102
-
1106
)
35
Kim
C
Kwok
YS
Heagerty
P
Redberg
R
Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis
Am Heart J
 , 
2001
, vol. 
142
 (pg. 
934
-
944
)
36
Rieber
J
Jung
P
Erhard
I
Koenig
A
Hacker
M
Schiele
TM
Segmiller
T
Stempfle
HU
Theisen
K
Siebert
U
Klauss
V
Comparison of pressure measurement, dobutamine contrast stress echocardiography and SPECT for the evaluation of intermediate coronary stenoses. The COMPRESS trial
Int J Cardiovasc Intervent
 , 
2004
, vol. 
6
 (pg. 
142
-
147
)
37
Deussen
A
Schrader
J
Cardiac adenosine production is linked to myocardial pO2
J Mol Cell Cardiol
 , 
1991
, vol. 
23
 (pg. 
495
-
504
)
38
Heusch
G
Baumgart
D
Camici
P
Chilian
W
Gregorini
L
Hess
O
Indolfi
C
Rimoldi
O
alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans
Circulation
 , 
2000
, vol. 
101
 (pg. 
689
-
694
)
39
Hori
M
Inoue
M
Kitakaze
M
Koretsune
Y
Iwai
K
Tamai
J
Ito
H
Kitabatake
A
Sato
T
Kamada
T
Role of adenosine in hyperemic response of coronary blood flow in microembolization
Am J Physiol
 , 
1986
, vol. 
250
 (pg. 
H509
-
H518
)
40
Gould
KL
Lipscomb
K
Effects of coronary stenoses on coronary flow reserve and resistance
Am J Cardiol
 , 
1974
, vol. 
34
 (pg. 
48
-
55
)
41
Siebert
U
The role of decision-analytic models in the prevention, diagnosis and treatment of coronary heart disease
Z Kardiol
 , 
2002
, vol. 
91
 
Suppl. 3
(pg. 
144
-
151
)
42
Weinstein
MC
Fineberg
HV
Elstein
AS
Frazier
HS
Neuhauser
D
Neutra
RR
McNeil
BJ
Clinical Decision Analysis
 , 
1980
1st ed.
Philadelphia
Saunders Company

Author notes

Johannes Rieber and Armin Huber equally contributed to this work

Supplementary data

Comments

0 Comments